The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access  to Imaging and Treatment of Metastatic Prostate Cancer

The forthcoming STAMPEDE2 trial has three comparisons in metastatic hormone-sensitive prostate cancer. We aim to determine clinical practices among STAMPEDE trial investigators for access to imaging and therapeutic choices and explore their interest in participation in STAMPEDE2.

Source: Clinical Oncology - July 21, 2023 Category: Radiology Authors: H. Abdel-Aty, L. O'Shea, C. Amos, L.C. Brown, E. Grist, G. Attard, N. Clarke, W. Cross, C. Parker, M. Parmar, N.vas As, N. James Tags: Original Article Source Type: research